In India, tens of thousands of people have contracted mucormycosis, better known as “black mold.” This was reported on the NDTV channel.
According to the publication, the number of cases of mucormycosis in the country has increased by 150 percent over the past three weeks and reached 31 thousand. At the same time, more than two thousand people died from complications caused by the disease.
It is noted that such a jump in morbidity is caused, among other things, by an acute shortage of the drug Amphotericin B, which is used to treat patients. The state of Maharashtra was the most affected – seven thousand cases of infection were recorded there, which is two and a half times more than at the end of May. In Delhi, 1,200 cases and 125 deaths were recorded.
Mucormycosis, or “black mold” is a complication that provokes a fungal infection. It enters the skin through a cut, scratch, or burn, as well as through direct contact with fungal spores in the environment. The disease is dangerous for patients with diabetes and weakened immunity, and especially for those who have had a coronavirus.
An outbreak of mucormycosis in coronavirus survivors was first recorded on May 9 by doctors in the Indian state of Gujarat. The victims of the infection are people with weakened immune systems. According to doctors, the cause of the disease may be in the steroids used to treat the coronavirus.